XBiotech Inc (XBIT) Implied Volatility Current

Tracking XBIT implied volatility helps you identify when options premiums on XBiotech Inc are historically cheap or expensive, and where the best trades are hiding. XBiotech Inc implied volatility reflects the market's expectation of future price movement: when XBIT IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor XBiotech Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For XBIT, tracking metrics like XBIT IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on XBIT signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation, and True Human COVID-19 therapy for treating the COVID-19 mutant virus.

The company was incorporated in 2005 and is headquartered in Austin, Texas.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where XBIT implied volatility sits today versus where it has been. Our scanner ranks XBiotech Inc implied volatility against its historical range, surfaces extremes in XBIT IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether XBiotech Inc IV is rich or cheap — measure it, then act on it.